Annual Cash & Cash Equivalents
$86.77 M
-$44.47 M-33.88%
31 December 2023
Summary:
Burning Rock Biotech Limited annual cash & cash equivalents is currently $86.77 million, with the most recent change of -$44.47 million (-33.88%) on 31 December 2023. During the last 3 years, it has fallen by -$137.78 million (-61.36%). BNR annual cash & cash equivalents is now -70.09% below its all-time high of $290.10 million, reached on 31 December 2020.BNR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$71.01 M
-$2.26 M-3.08%
30 September 2024
Summary:
Burning Rock Biotech Limited quarterly cash and cash equivalents is currently $71.01 million, with the most recent change of -$2.26 million (-3.08%) on 30 September 2024. Over the past year, it has dropped by -$15.76 million (-18.16%). BNR quarterly cash and cash equivalents is now -80.38% below its all-time high of $361.86 million, reached on 30 June 2020.BNR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BNR Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -18.2% |
| 3 y3 years | -61.4% | -68.4% |
| 5 y5 years | +544.3% | +427.3% |
BNR Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.4% | at low | -68.4% | at low |
| 5 y | 5 years | -70.1% | +544.3% | -80.4% | +427.3% |
| alltime | all time | -70.1% | +544.3% | -80.4% | +427.3% |
Burning Rock Biotech Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $71.01 M(-3.1%) |
| June 2024 | - | $73.27 M(-8.9%) |
| Mar 2024 | - | $80.47 M(-7.3%) |
| Dec 2023 | $86.77 M(-33.9%) | $86.77 M(-0.5%) |
| Sept 2023 | - | $87.21 M(-13.6%) |
| June 2023 | - | $100.99 M(-12.4%) |
| Mar 2023 | - | $115.30 M(-12.1%) |
| Dec 2022 | $131.24 M | $131.24 M(-7.4%) |
| Sept 2022 | - | $141.70 M(-17.3%) |
| June 2022 | - | $171.39 M(-13.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $199.10 M(-11.3%) |
| Dec 2021 | $224.55 M(-22.6%) | $224.55 M(-10.4%) |
| Sept 2021 | - | $250.58 M(-12.6%) |
| June 2021 | - | $286.61 M(-9.5%) |
| Mar 2021 | - | $316.80 M(+9.2%) |
| Dec 2020 | $290.10 M(+2053.9%) | $290.10 M(-3.9%) |
| Sept 2020 | - | $301.99 M(-16.5%) |
| June 2020 | - | $361.86 M(+607.7%) |
| Mar 2020 | - | $51.13 M(+279.6%) |
| Dec 2019 | $13.47 M(-0.7%) | $13.47 M |
| Dec 2018 | $13.57 M | - |
FAQ
- What is Burning Rock Biotech Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Burning Rock Biotech Limited?
- What is Burning Rock Biotech Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Burning Rock Biotech Limited?
- What is Burning Rock Biotech Limited quarterly cash and cash equivalents year-on-year change?
What is Burning Rock Biotech Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of BNR is $86.77 M
What is the all time high annual cash & cash equivalents for Burning Rock Biotech Limited?
Burning Rock Biotech Limited all-time high annual cash & cash equivalents is $290.10 M
What is Burning Rock Biotech Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BNR is $71.01 M
What is the all time high quarterly cash and cash equivalents for Burning Rock Biotech Limited?
Burning Rock Biotech Limited all-time high quarterly cash and cash equivalents is $361.86 M
What is Burning Rock Biotech Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, BNR quarterly cash and cash equivalents has changed by -$15.76 M (-18.16%)